{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-015780","form_type":"8-K","ticker":null,"cik":"0001267813","company_name":"MARINUS PHARMACEUTICALS, INC.","filed_at":"2024-11-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.933634+00:00","generated_at":"2026-05-29T23:37:42.912743+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Three directors resign from Marinus board; board size reduced to six","bullets":["Charles Austin, Dr. Nochur, and Dr. Noonberg resigned effective Nov 14, 2024; resignations not due to any disagreement with the Company.","Board authorized size decreased from nine to six directors immediately following resignations.","No replacements named; three vacancies remain on the Board."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-015780","json":"https://secwatch.observer/filing/0001558370-24-015780.json","markdown":"https://secwatch.observer/filing/0001558370-24-015780.md","text":"https://secwatch.observer/filing/0001558370-24-015780.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1267813/000155837024015780/0001558370-24-015780-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1267813/000155837024015780/mrns-20241114x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T23:37:42.912743+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1a149dfdae","claim":"Sarah Noonberg resigned as Director at MARINUS PHARMACEUTICALS, INC..","evidence_excerpt":"On November 14, 2024, each of Charles Austin, Saraswathy V. Nochur, Ph.D. and Sarah Noonberg, M.D., Ph.D., resigned from the Board of Directors of Marinus Pharmaceuticals, Inc. (the \"Company\") , effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1267813/000155837024015780/0001558370-24-015780-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"3f58313ca5","claim":"Charles Austin resigned as Director at MARINUS PHARMACEUTICALS, INC..","evidence_excerpt":"On November 14, 2024, each of Charles Austin, Saraswathy V. Nochur, Ph.D. and Sarah Noonberg, M.D., Ph.D., resigned from the Board of Directors of Marinus Pharmaceuticals, Inc. (the \"Company\") , effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1267813/000155837024015780/0001558370-24-015780-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"6407327c26","claim":"Saraswathy V. Nochur resigned as Director at MARINUS PHARMACEUTICALS, INC..","evidence_excerpt":"On November 14, 2024, each of Charles Austin, Saraswathy V. Nochur, Ph.D. and Sarah Noonberg, M.D., Ph.D., resigned from the Board of Directors of Marinus Pharmaceuticals, Inc. (the \"Company\") , effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1267813/000155837024015780/0001558370-24-015780-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}